GoodRx vs Hinge Health
GDRX and HNGE side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GDRX and HNGE compare
Hinge Health is the larger company, worth 7.7 times as much as GoodRx ($9.2B against $1.2B).
Hinge Health grew revenue faster over the last twelve months (49.8% versus −1.8% for GoodRx).
Hinge Health keeps more of each dollar of sales as profit, with a net margin of 15.1% compared with 2.1% at GoodRx.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GDRX | HNGE |
|---|---|---|
| Size and price | ||
| Market cap | $1.2B | $9.2B |
| Share price | $3.49 | $114.32 |
| Change, 1 year | −0.85% | 130% |
| Change, 5 years | −92.0% | – |
| Beta (5Y) | 1.72 | 1.68 |
| Employees | 697 | 1,437 |
| StockData Score | ||
| Total score | 11 | 11 |
| Valuation score | 4 (better) | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 3 (better) | 2 |
| Health score | 3 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 87.3× | – |
| P/S | 1.5× (better) | 12.8× |
| P/B | 1.8× (better) | 26.8× |
| EV/EBITDA | 8.4× (better) | 89.8× |
| P/FCF | 6.0× (better) | 31.8× |
| FCF yield | 16.6% (better) | 3.1% |
| Fair value | $5.53 | – |
| Margin of safety | 36.9% | – |
| Growth | ||
| Revenue growth (TTM) | −1.8% | 49.8% (better) |
| Revenue growth, 5Y average | 7.7% | – |
| Net income growth (TTM) | −53.0% | – |
| EPS growth (TTM) | −60.0% | – |
| Profitability | ||
| Gross margin | 90.8% (better) | 84.5% |
| Operating margin | 9.5% | 13.0% (better) |
| Net margin | 2.1% | 15.1% (better) |
| FCF margin | 25.1% | 40.3% (better) |
| Return on equity | 2.5% | 42.1% (better) |
| Return on invested capital | 4.4% | – |
| Financial health | ||
| Debt / equity | 0.75 (better) | 0.00 |
| Net debt / EBITDA | 1.16 | – |
| Interest coverage | 1.8× | – |
| Current ratio | 1.38 (better) | 1.34 |
| Altman Z-score | 0.25 | 11.29 (better) |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | 7.1% | – |
| Shareholder yield | 7.1% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 34.8% | 72.0% |
| Held by insiders | 45.6% | 50.7% |
| Insider net buying, 12 months | −$9.7M (better) | −$517M |
| Short interest, % of float | 2.2% | 15.9% |
Go deeper
- GDRX stock overview
- GDRX income statement
- GDRX valuation and score
- HNGE stock overview
- HNGE income statement
- HNGE valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.